Cytokinetics, Incorporated Made Headway
Wed, Dec 27, 2023 at 11:31 PM
Cytokinetics, Incorporated (CYTK:NASDAQ) jumped higher at $83.44, representing a gain of 82.5%. On Wed, Dec 27, 2023, CYTK:NASDAQ touched a New 2-Week High of $83.44. The stock got featured on our News Catalysts scanner on Wed, Dec 27, 2023 at 06:15 PM in the 'MISCELLANEOUS' category. From Thu, Dec 14, 2023, the stock recorded 62.50% Up Days and 44.44% Green Days
About Cytokinetics, Incorporated (CYTK:NASDAQ)
Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
Top 10 Gainers:
- Oncorus Inc. (ONCR:NASDAQ), 669.23%
- Esports Technologies Inc. (EBET:NASDAQ), 244.43%
- RiskOn International Inc Com Par $0.001 (ROI:NASDAQ), 205.4%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 110.74%
- Cingulate Inc. (CING:NASDAQ), 90.91%
- Cytokinetics, Incorporated (CYTK:NASDAQ), 82.54%
- Earlyworks Co. Ltd. (ELWS:NASDAQ), 69.31%
- Erayak Power Solution Group Inc. (RAYA:NASDAQ), 50.73%
- First Wave BioPharma Inc. (FWBI:NASDAQ), 50.27%
- Vince Holding Corp. (VNCE:NYSE), 48.68%